CIK 0001816736 · Large accelerated filer
Disc Medicine, Inc.
Sign in to watch- Ticker
- IRON
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 851612845
- Phone
- (617) 674-9274
- Business address
- 321 ARSENAL STREET, SUITE 101, WATERTOWN, MA, 02472
- Former names
- Gemini Therapeutics, Inc. /DE, FS Development Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $14,489,047
- in 7 filings, $12.6M under 10b5-1 plans
Net −$14,489,047. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-04 | Bitterman Kevin Director | Sale 10b5-1 | −759 | $79.96 | $61K | 312,230 |
| 2026-09-04 | Bitterman Kevin Director | Sale 10b5-1 | −18 | $79.96 | $1K | 13,427 |
| 2026-09-03 | Bitterman Kevin Director | Sale 10b5-1 | −2,810 | $79.98 | $225K | 319,778 |
| 2026-09-03 | Bitterman Kevin Director | Sale 10b5-1 | −2,339 | $79.98 | $187K | 312,989 |
| 2026-09-03 | Bitterman Kevin Director | Sale 10b5-1 | −54 | $79.98 | $4K | 13,445 |
| 2026-09-02 | Bitterman Kevin Director | Sale 10b5-1 | −26,542 | $80.17 | $2.1M | 322,598 |
| 2026-09-02 | Bitterman Kevin Director | Sale 10b5-1 | −22,090 | $80.17 | $1.8M | 315,337 |
| 2026-09-02 | Bitterman Kevin Director | Sale 10b5-1 | −511 | $80.17 | $41K | 13,501 |
| 2026-09-02 | Bitterman Kevin Director | Sale 10b5-1 | −10 | $80.98 | $810 | 322,588 |
| 2026-09-02 | Bitterman Kevin Director | Sale 10b5-1 | −9 | $80.98 | $729 | 315,328 |
| 2026-09-02 | Bitterman Kevin Director | Sale 10b5-1 | −2 | $80.98 | $162 | 13,499 |
| 2026-09-01 | Bitterman Kevin Director | Sale 10b5-1 | −70 | $79.95 | $6K | 349,140 |
| 2026-09-01 | Bitterman Kevin Director | Sale 10b5-1 | −58 | $79.95 | $5K | 337,427 |
| 2026-09-01 | Bitterman Kevin Director | Sale 10b5-1 | −1 | $79.95 | $80 | 14,012 |
| 2026-08-25 | Yu Jonathan Yen-Wen Chief Operating Officer | Option exercise 10b5-1 | +8,796 | $13.50 | $119K | 63,120 |
| 2026-08-25 | Yu Jonathan Yen-Wen Chief Operating Officer | Sale 10b5-1 | −8,796 | $83.12 | $731K | 54,324 |
| 2026-08-25 | Yu Jonathan Yen-Wen Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −8,796 | 13,847 | ||
| 2026-08-24 | Yu Jonathan Yen-Wen Chief Operating Officer | Option exercise 10b5-1 | +300 | $13.50 | $4K | 54,624 |
| 2026-08-24 | Yu Jonathan Yen-Wen Chief Operating Officer | Sale 10b5-1 | −300 | $82.53 | $25K | 54,324 |
| 2026-08-24 | Yu Jonathan Yen-Wen Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −300 | 22,643 |
Page 2 of 17 · 337 trades